THE SU5408 DIARIES

More experiments in NOD/SCID mice seemed to evaluate the motion of avatrombopag in vivo. Human fetal liver CD34+ cells ended up transplanted into NOD/SCID mice, with human platelets showing four months immediately after transplant. Administration of avatrombopag triggered a rise in the manufacture of human platelets without possessing an effect on